Protective immunity against Helicobacter is characterized by a unique transcriptional signature

被引:52
作者
Mueller, A
O'Rourke, J
Chu, P
Kim, CC
Sutton, P
Lee, A
Falkow, S
机构
[1] Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA
[2] Stanford Univ, Sch Med, Dept Comparat Med, Stanford, CA 94305 USA
[3] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia
关键词
rodent; lymphocytes; bacterial infections; vaccination; mucosa;
D O I
10.1073/pnas.1635231100
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Immunization with a whole-cell sonicate vaccine of Helicobacter felis in conjunction with cholera toxin as a mucosal adjuvant induces long-term protective immunity in a majority of laboratory mice. We have combined gene expression profiling and immunohistochemical analysis on a set of immunized animals to better understand the mechanism of protection. The stomachs of protected animals exhibited a strikingly different transcriptional profile compared with those of nonprotected or control mice, indicating that vaccination targets the appropriate site and leaves a molecular signature. Among the genes whose up-regulation is significantly correlated with protection are a number of adipocyte-specific factors. These include the fat-cell-specific cytokines adipsin, resistin, and adiponectin and the adipocyte surface marker CD36. Interestingly, potentially protective T and B lymphocytes can be found embedded in the adipose tissue surrounding protected stomachs but never in control or unprotected stomachs. Adipsin-specific immunohistochemical staining of protected stomach sections further revealed molecular cross-talk between adjacent lymphoid and adipose cell populations. We propose a mechanism of protection that involves the effector responses of either or both lymphocyte subclasses as well as the previously unappreciated paracrine functions of adipose tissue surrounding the resident lymphocytes.
引用
收藏
页码:12289 / 12294
页数:6
相关论文
共 49 条
  • [1] Pilot study of phoP/phoQ-deleted Salmonella enterica serovar Typhimurium expressing Helicobacter pylori urease in adult volunteers
    Angelakopoulos, H
    Hohmann, EL
    [J]. INFECTION AND IMMUNITY, 2000, 68 (04) : 2135 - 2141
  • [2] CXCL13 is required for B1 cell homing, natural antibody production, and body cavity immunity
    Ansel, KM
    Harris, RBS
    Cyster, JG
    [J]. IMMUNITY, 2002, 16 (01) : 67 - 76
  • [3] Lymphocytes in the human gastric mucosa during Helicobacter pylori have a T helper cell 1 phenotype
    Bamford, KB
    Fan, XJ
    Crowe, SE
    Leary, JF
    Gourley, WK
    Luthra, GK
    Brooks, EG
    Graham, DY
    Reyes, VE
    Ernst, PB
    [J]. GASTROENTEROLOGY, 1998, 114 (03) : 482 - 492
  • [4] Antibody-independent protective mucosal immunity to gastric Helicobacter infection in mice
    Blanchard, TG
    Czinn, SJ
    Redline, RW
    Sigmund, N
    Harriman, G
    Nedrud, JG
    [J]. CELLULAR IMMUNOLOGY, 1999, 191 (01) : 74 - 80
  • [5] Safety and immunogenicity of live recombinant Salmonella enterica serovar Typhi Ty21a expressing urease A and B from Helicobacter pylori in human volunteers
    Bumann, D
    Metzger, WG
    Mansouri, E
    Palme, O
    Wendland, M
    Hurwitz, R
    Haas, G
    Aebischer, T
    von Specht, BU
    Meyer, TF
    [J]. VACCINE, 2001, 20 (5-6) : 845 - 852
  • [6] IMMUNIZATION AGAINST GASTRIC HELICOBACTER INFECTION IN A MOUSE HELICOBACTER-FELIS MODEL
    CHEN, MH
    LEE, A
    HAZELL, S
    [J]. LANCET, 1992, 339 (8801) : 1120 - 1121
  • [7] Leptin induces angiopoietin-2 expression in adipose tissues
    Cohen, B
    Barkan, D
    Levy, Y
    Goldberg, I
    Fridman, E
    Kopolovic, J
    Rubinstein, M
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (11) : 7697 - 7700
  • [8] Safety and immunogenicity of phoP/phoQ-deleted Salmonella typhi expressing Helicobacter pylori urease in adult volunteers
    DiPetrillo, MD
    Tibbetts, T
    Kleanthous, H
    Killeen, KP
    Hohmann, EL
    [J]. VACCINE, 1999, 18 (5-6) : 449 - 459
  • [9] DOIDGE C, 1994, LANCET, V343, P914, DOI 10.1016/S0140-6736(94)90032-9
  • [10] Gastric MALT lymphoma: from aetiology to treatment
    Du, MQ
    Isaccson, PG
    [J]. LANCET ONCOLOGY, 2002, 3 (02) : 97 - 104